Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following Stroke
NCT07759791, Not applicable, Recruiting, Queen's University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following Stroke | ClinicalTrials.gov |
| NCT number | NCT07759791 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 118 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Queen's University | ClinicalTrials.gov |
| Conditions | Stroke | ClinicalTrials.gov |
| Interventions | Occupational Performance Coaching (OPC), computer cognitive training program (CogniFit) | ClinicalTrials.gov |
| First posted | 2026-08-12 | ClinicalTrials.gov |
| Last updated | 2026-08-12 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Canadian Occupational Performance Measure (COPM) | Baseline, periprocedural, and 3-months after periprocedural assessment | The Canadian Occupational Performance Measure (COPM) is a reliable, valid, and responsive tool frequently used in stroke rehabilitation outcome studies. Using the COPM, participants identify problems related to participation in valued activities that are then rated by participants for performance and satisfaction with current status on a scale of 1-10, where 10 indicates optimal performance or satisfaction. Numbers are summed and divided by the number of goals. | ClinicalTrials.gov |
| Secondary | Participation Strategies Self-Efficacy Scale (PS-SES) | Baseline, periprocedural, and 3-months after periprocedural assessment | The Participation Strategies Self-Efficacy Scale (PS-SES) is a 35-item scale that measures self-efficacy in using strategies for participation in home, community, work, and social activities. Each item is scored on a scale of 1 (not at all confident) to 10 (totally confident) total score ranges from 35 to 350 with higher scores indicating higher self-efficacy. | ClinicalTrials.gov |
| Secondary | Time spent in active veruss sedentary activity | Baseline, periprocedural, and 3-months after periprocedural assessment | Time spent in active (i.e., standing, walking) versus sedentary (i.e., sitting, lying) activites willk be measured using the ActivPal 4 activity monitor (PAL Technologies Ltd., Glasgow, UK). The ActivPal is a small, lightweight wearable device that measures movement with a triaxial accelerometer and body posture with a gyroscope. Consistent with recommendations for obtaining a good representation of typical physical activity, it will be worn for seven consecutive days ateach data colleciton timepoint. An average of active versus sedentary time will be calculated. | ClinicalTrials.gov |
| Secondary | Generalized Anxiety Disorders Scale-7 (GAD-7) | Baseline, periprocedural, and 3-months after periprocedural assessment | The Generalized Anxiety Disorders Scale-7 (GAD-7) is a brief 7-item screening tool for anxiety that captures the frequency of anxiety-related symptoms. The GAD-7 is a valid, reliable, and responsive measure commonly used in stroke rehabilitation research. Items are socred on a scale of 0 (not at all) to 3 (nearly everyday). Total score ranges from 0-21 with higher scores indicating higher anxiety. | ClinicalTrials.gov |
| Secondary | Executive Functioning | Baseline, periprocedural, and 3-months after periprocedural assessment | Executive functioning will be measured using the following CogniFit computerized assessments : a) the Trail Making Test (TMT) measures processing speed, shifting and visual attention; b) the Stroop test measures inhibition, updating, visual perception, naming, processing speed and response time; and c) the Visual Working Memory Span Test measures spatial perception, short-term memory, visual short-term memory, non-verbal memory, working memory, planning, processing speed, and response time. These tests have demonstrated reliability and validity with older adults. Overall executive functioning will be represented using Z scores. | ClinicalTrials.gov |
| Secondary | Brief Patient Health Questionnaire (PhQ-9) | Baseline, periprocedural, and 3-months after periprocedural assessment | The Brief Patient Health Questionnaire (PHQ-9) is a brief 9-item screening tool for depression. PhQ-9 is a valid, reliable, and responsive measure commonly used in stroke rehabilitation research. Items are scored on a scale of 0 (not at all) to 3 (nearly every day). Total score ranges form 0 to 27 with higher scores indicating higher depression. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)